FDA Approves Gabapentin Capsules (gabapentin) for Postherpetic Neuralgia and Partial Onset Seizures
FDA approves a new generic version of the drug gabapentin for nerve pain and seizures
The FDA has approved Gabapentin Capsules, USP for the management of postherpetic neuralgia in adults and as adjunctive therapy for partial o…
FDA approves a new generic gabapentin capsule for nerve pain and seizures, offering patients another low-cost treatment option alongside exi…
Meta-analysis finds no significant differences between pCASL and DSC perfusion MRI in hyperacute ischemic stroke
MRI technique shows promise for stroke imaging but evidence remains limited
A systematic review and meta-analysis of 383 ischemic stroke patients found no significant differences between pseudocontinuous arterial spi…
A new MRI scan that avoids injected dye shows similar results to standard tests for detecting early stroke damage, though more research is n…
Systematic review examines neuroprotective plant extracts for Parkinson's disease mechanisms
Review explores how plant extracts might protect brain cells in Parkinson's disease
A systematic review summarized preclinical and clinical research on plant extracts with neuroprotective properties for Parkinson's disease.
Plant extracts might protect brain cells in Parkinson's disease by reducing inflammation, stopping protein clumping, and helping nerve conne…
NeuroFM foundation model enables brain health profiling and dementia risk estimation from MRI
Can a single brain scan model predict your future dementia risk?
A cohort study evaluated NeuroFM, a foundation model trained on 100,000 synthetic brain volumes and tested on 136,361 real volumes.
A new brain scan model learned from healthy images to spot dementia risk years before diagnosis without needing disease labels.
FDA Approves Valproic Acid Oral Solution (valproic acid) for Complex Partial and Absence Seizures
The FDA has approved a liquid form of an older seizure medicine called valproic acid
Valproic acid oral solution is approved as monotherapy and adjunctive therapy for complex partial seizures and for simple and complex absenc…
The FDA approved a liquid version of valproic acid to help adults and children over 10 manage complex partial and absence seizures when pill…
FDA Approves Valproic Acid Oral Solution (valproic acid) for Monotherapy and Adjunctive Therapy of Complex Partial and Absence Seizures
FDA approves a liquid form of an existing epilepsy medicine called valproic acid
The FDA has approved valproic acid oral solution for monotherapy and adjunctive therapy of complex partial seizures, and as sole and adjunct…
FDA approves liquid valproic acid for epilepsy patients 10 and older who struggle to swallow pills or need flexible dosing.
FDA Approves Valproic Acid Oral Solution (valproic acid) for Monotherapy and Adjunctive Therapy of Complex Partial and Absence Seizures
The FDA has approved a liquid form of an existing epilepsy and migraine prevention medicine
The FDA has approved valproic acid oral solution for monotherapy and adjunctive therapy of complex partial seizures, and as sole and adjunct…
The FDA approved a liquid version of valproic acid, an established epilepsy and migraine medicine, offering an easier swallowing option for …
Digital memory assessment and plasma pTau217 identify preclinical Alzheimer's disease participants at elevated risk for progression
Two simple tests may help find early Alzheimer's risk faster
This analysis of data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study evaluated cognitively unimpaired, amylo…
Two simple tests can spot older adults at high risk for Alzheimer's decline, helping doctors find the right patients faster for new treatmen…
AI approaches show potential for mapping brain-heart network interactions in neurocardiology
Can AI help us understand the hidden conversation between our brain and heart?
A systematic review explores artificial intelligence approaches for mapping and predicting brain-heart network dynamics across conditions li…
Artificial intelligence may decode the silent conversation between your brain and heart to spot hidden patterns in conditions like heart fai…
Direct Transfer to Angiography Suite Shows No Benefit, Higher Hemorrhage Risk in Severe Stroke
Does rushing stroke patients straight to treatment improve their recovery?
A randomized trial in 115 adults with acute severe stroke from large vessel occlusion compared direct transfer to angiography suite (DTAS) w…
Skipping the CT scan to rush stroke patients straight to treatment did not improve recovery and increased the risk of serious brain bleeding…
Neuromodulation for pediatric disorders of consciousness lacks specific pediatric evidence
Review finds limited evidence for brain stimulation in children with consciousness disorders
A systematic review synthesized adult-derived evidence for neuromodulation (tDCS, rTMS, DBS) in pediatric disorders of consciousness.
Brain stimulation for children with consciousness disorders lacks safety proof because kids' developing brains differ from adults, creating …
Plasma biomarkers diverge sequentially up to 26 years before symptom onset in autosomal dominant Alzheimer's disease
Can a blood test spot Alzheimer's risk decades before symptoms appear?
A longitudinal cohort study of 73 ADAD mutation carriers and 40 non-carriers found eight plasma biomarkers elevated sequentially from 26 to …
A blood test can spot Alzheimer's risk up to 26 years before symptoms appear in people with a specific inherited gene mutation.